Annual EBITDA
Summary
- Current Value
- As of today, ELV annual EBITDA is $8.26B, down -11.20% on
- Historical Performance
- ELV annual EBITDA is down -10.99% over the past 3 years, and up +11.69% over the past 5 years
- All-Time High Comparison
- ELV annual EBITDA is currently -12.73% below its historical high of $9.46B set on
- 3-Year Low Comparison
- ELV annual EBITDA is at its 3-year low
- Sector Comparison
- ELV annual EBITDA is higher than 99.14% of companies in Healthcare sector
EBITDA Chart
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $8.26B | -11.2% | -11.0% | +11.7% | +66.6% | |
| Quarterly EBITDA | $621.00M | -38.1% | -59.1% | -31.1% | -31.8% | |
| TTM EBITDA | $8.26B | -11.2% | -11.0% | +11.7% | +66.6% | |
| Price | $330.25 | -15.6% | -32.7% | +12.8% | +406.1% | |
| PE Ratio | 13.15 | -13.9% | -35.0% | -19.5% | +39.3% | |
| Annual Revenue | $199.13B | +12.6% | +27.2% | +63.4% | +238.4% | |
| Annual EPS | $25.21 | -1.8% | +3.9% | +40.2% | +263.3% | |
| $6.71B | -15.1% | -11.7% | +7.6% | +54.1% | ||
| Annual Net Income | $5.66B | -5.2% | -3.9% | +23.8% | +96.1% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $9.46B | -12.7% | |
| 5Y | $9.46B | -12.7% | |
| All | $9.46B | -12.7% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $8.26B | at low | |
| 5Y | $7.39B | N/A | +11.7% |
| All | $964.60M | +755.9% |
EBITDA History
FAQ
What is the current annual EBITDA of ELV?
As of today, ELV annual EBITDA is $8.26B
What is 1-year change in ELV annual EBITDA?
ELV annual EBITDA is down -11.20% year-over-year
What is 3-year change in ELV annual EBITDA?
ELV annual EBITDA is down -10.99% over the past 3 years
How far is ELV annual EBITDA from its all-time high?
ELV annual EBITDA is currently -12.73% below its historical high of $9.46B set on December 31, 2023
How does ELV annual EBITDA rank versus sector peers?
ELV annual EBITDA is higher than 99.14% of companies in Healthcare sector
When is ELV next annual earnings release?
As of today, the next annual earnings release for ELV has not been scheduled
Quarterly EBITDA
Summary
- Current Value
- As of today, ELV quarterly EBITDA is $621.00M, down -65.37% on
- Historical Performance
- ELV quarterly EBITDA is down -38.15% year-over-year, and down -59.09% over the past 3 years
- All-Time High Comparison
- ELV quarterly EBITDA is currently -86.13% below its historical high of $4.48B set on
- 3-Year Low Comparison
- ELV quarterly EBITDA is at its 3-year low
- Sector Comparison
- ELV quarterly EBITDA is higher than 96.79% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $621.00M | -65.4% | -38.1% | -59.1% | -31.1% | |
| Annual EBITDA | $8.26B | – | -11.2% | -11.0% | +11.7% | |
| TTM EBITDA | $8.26B | -4.4% | -11.2% | -11.0% | +11.7% | |
| Price | $330.25 | +4.8% | -15.6% | -32.7% | +12.8% | |
| PE Ratio | 13.15 | +2.0% | -13.9% | -35.0% | -19.5% | |
| Quarterly Revenue | $49.75B | -1.9% | +9.5% | +24.6% | +56.3% | |
| Quarterly EPS | $2.47 | -53.6% | +36.4% | -31.2% | +12.4% | |
| $215.00M | -84.7% | -64.5% | -79.4% | -64.8% | ||
| Quarterly Net Income | $546.00M | -54.0% | +32.2% | -37.7% | -0.9% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.17B | -80.4% | |
| 3Y | $3.32B | -81.3% | |
| 5Y | $3.32B | -81.3% | |
| All | $4.48B | -86.1% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $621.00M | at low | |
| 3Y | $621.00M | at low | |
| 5Y | $621.00M | at low | |
| All | $215.20M | +188.6% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of ELV?
As of today, ELV quarterly EBITDA is $621.00M
What is ELV quarterly EBITDA most recent change?
ELV quarterly EBITDA was down -65.37% on December 31, 2025
What is 1-year change in ELV quarterly EBITDA?
ELV quarterly EBITDA is down -38.15% year-over-year
How far is ELV quarterly EBITDA from its all-time high?
ELV quarterly EBITDA is currently -86.13% below its historical high of $4.48B set on December 31, 2009
How does ELV quarterly EBITDA rank versus sector peers?
ELV quarterly EBITDA is higher than 96.79% of companies in Healthcare sector
When is ELV next earnings release?
The next earnings release for ELV is on
TTM EBITDA
Summary
- Current Value
- As of today, ELV TTM EBITDA is $8.26B, down -4.43% on
- Historical Performance
- ELV TTM EBITDA is down -11.20% year-over-year, and down -10.99% over the past 3 years
- All-Time High Comparison
- ELV TTM EBITDA is currently -18.23% below its historical high of $10.10B set on
- 3-Year Low Comparison
- ELV TTM EBITDA is at its 3-year low
- Sector Comparison
- ELV TTM EBITDA is higher than 98.90% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $8.26B | -4.4% | -11.2% | -11.0% | +11.7% | |
| Annual EBITDA | $8.26B | – | -11.2% | -11.0% | +11.7% | |
| Quarterly EBITDA | $621.00M | -65.4% | -38.1% | -59.1% | -31.1% | |
| Price | $330.25 | +4.8% | -15.6% | -32.7% | +12.8% | |
| PE Ratio | 13.15 | +2.0% | -13.9% | -35.0% | -19.5% | |
| TTM Revenue | $199.13B | +2.2% | +12.6% | +27.2% | +63.4% | |
| TTM EPS | $25.11 | +2.7% | -2.0% | +3.5% | +40.1% | |
| $6.71B | -5.5% | -15.1% | -11.7% | +7.6% | ||
| TTM Net Income | $5.66B | +2.4% | -5.2% | -3.9% | +23.8% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $9.30B | N/A | -11.2% |
| 3Y | $10.10B | -18.2% | |
| 5Y | $10.10B | -18.2% | |
| All | $10.10B | -18.2% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $8.26B | at low | |
| 3Y | $8.26B | at low | |
| 5Y | $6.72B | +22.9% | |
| All | $215.20M | +3736.4% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of ELV?
As of today, ELV TTM EBITDA is $8.26B
What is ELV TTM EBITDA most recent change?
ELV TTM EBITDA was down -4.43% on December 31, 2025
What is 1-year change in ELV TTM EBITDA?
ELV TTM EBITDA is down -11.20% year-over-year
How far is ELV TTM EBITDA from its all-time high?
ELV TTM EBITDA is currently -18.23% below its historical high of $10.10B set on June 30, 2024
How does ELV TTM EBITDA rank versus sector peers?
ELV TTM EBITDA is higher than 98.90% of companies in Healthcare sector
When is ELV next earnings release?
The next earnings release for ELV is on
EBITDA Formula
Data Sources & References
- ELV Official Website www.elevancehealth.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1156039/000115603926000006/0001156039-26-000006-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1156039/000115603926000006/0001156039-26-000006-index.htm
- ELV Profile on Yahoo Finance finance.yahoo.com/quote/ELV
- ELV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/elv
